+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Heterocycles 149771-44-8
149771-44-8,MFCD17016708
Catalog No.:AA001LXM

149771-44-8 | 8-Boc-3,8-diaza-bicyclo[3.2.1]octane

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
96%
in stock  
$8.00   $6.00
- +
1g
96%
in stock  
$19.00   $14.00
- +
5g
98%
in stock  
$53.00   $37.00
- +
10g
98%
in stock  
$103.00   $72.00
- +
25g
98%
in stock  
$256.00   $179.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001LXM
Chemical Name:
8-Boc-3,8-diaza-bicyclo[3.2.1]octane
CAS Number:
149771-44-8
Molecular Formula:
C11H20N2O2
Molecular Weight:
212.2887
MDL Number:
MFCD17016708
SMILES:
O=C(N1C2CNCC1CC2)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
248  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
2  
XLogP3:
1.1  

Upstream Synthesis Route

[1]JournalofMedicinalChemistry,1998,vol.41,#5,p.674-681

[2]Patent:US2002/128271,2002,A1,

[3]Patent:EP1213289,2002,A1,.Locationinpatent:Page13

[4]Patent:WO2006/106090,2006,A1,.Locationinpatent:Page/Pagecolumn16

[5]TetrahedronLetters,2002,vol.43,#5,p.899-902

[6]Farmaco,1993,vol.48,#3,p.387-396

[7]Farmaco,1998,vol.53,#8-9,p.557-562

[8]Patent:US9404081,2016,B2,.Locationinpatent:Page/Pagecolumn179

[1]Patent:US2005/65178,2005,A1,.Locationinpatent:Page/Pagecolumn18

[2]Patent:US2005/101602,2005,A1,.Locationinpatent:Page/Pagecolumn26

[3]Patent:US2005/9841,2005,A1,.Locationinpatent:Page/Pagecolumn15

[4]Patent:US2005/80095,2005,A1,.Locationinpatent:Page/Pagecolumn17

[1]TetrahedronLetters,2002,vol.43,#5,p.899-902

[2]Farmaco,1998,vol.53,#8-9,p.557-562

[3]JournalofMedicinalChemistry,1998,vol.41,#5,p.674-681

[4]Farmaco,1993,vol.48,#3,p.387-396

[5]Patent:US9404081,2016,B2,

[1]JournalofMedicinalChemistry,1998,vol.41,#5,p.674-681

[2]Farmaco,1993,vol.48,#3,p.387-396

[1]TetrahedronLetters,2002,vol.43,#5,p.899-902

[2]Patent:US9404081,2016,B2,

Downstream Synthesis Route

[1]JournalofMedicinalChemistry,1998,vol.41,p.674-681

[2]Patent:US2002/128271,2002,A1

[3]Patent:EP1213289,2002,A1.Locationinpatent:Page13

[4]Patent:WO2006/106090,2006,A1.Locationinpatent:Page/Pagecolumn16

[5]TetrahedronLetters,2002,vol.43,p.899-902

[6]IlFarmaco,1993,vol.48,p.387-396

[7]IlFarmaco,1998,vol.53,p.557-562

[8]Patent:US9404081,2016,B2.Locationinpatent:Page/Pagecolumn179

[1]Patent:US2007/270405,2007,A1.Locationinpatent:Page/Pagecolumn50

[2]Patent:WO2009/67108,2009,A1.Locationinpatent:Page/Pagecolumn68-69

149771-44-8   
(+/-)-3-8-cyclohexyl-5-(dimethylamino)sulfonylaminocarbonyl-1,12b-dihydro-11-methoxycyclopropdindolo2,1-a2benzazepin-1a(2H)-ylcarbonyl-3,8-diazabicyclo3.2.1octane-8-carboxylicacid1,1-dimethylethylester 

[1]Patent:US2007/270405,2007,A1.Locationinpatent:Page/Pagecolumn53

[1]Patent:WO2007/141504,2007,A1.Locationinpatent:Page/Pagecolumn68

[2]JournalofMedicinalChemistry,2014,vol.57,p.1855-1879

1012317-17-7    149771-44-8   
C27H33F2N7O3 

[1]Patent:WO2008/32064,2008,A1.Locationinpatent:Page/Pagecolumn101

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 149771-44-8
1403676-97-0

1403676-97-0

 1000576-83-9

1000576-83-9

 1000931-58-7

1000931-58-7

 1018443-32-7

1018443-32-7

 1027511-69-8

1027511-69-8

 1169762-18-8

1169762-18-8
Building Blocks
More >
Tags:149771-44-8 Molecular Formula|149771-44-8 MDL|149771-44-8 SMILES|149771-44-8 8-Boc-3,8-diaza-bicyclo[3.2.1]octane